PharmaCielo Announces Annual General Meeting and Intention to Issue Interest Shares

Executive Summary

• PharmaCielo Ltd. announced its Annual General Meeting (AGM) will be held on April 2, 2026, with a record date of February 23, 2026.
• The company intends to issue 12,153,937 “Interest Shares” at $0.08 per share to settle $972,317.12 of accrued semi‑annual interest on its 11% secured debentures, subject to TSX Venture Exchange approval.
• The issuance price was calculated by dividing the cash interest payable by the number of shares issuable under each debenture, in accordance with applicable policies.

Key Details

• AGM Information – Date: April 2, 2026; Record date for voting rights: February 23, 2026. Materials will be filed on SEDAR+.
• Interest Shares Issuance – 12,153,937 common shares to be issued at an effective price of $0.08 per share.
• Purpose of Issuance – To satisfy accrued semi‑annual interest payments totaling $972,317.12 on the Company’s 11% secured debentures.
• Approval Required – Subject to approval by the TSX Venture Exchange and compliance with TSX Venture Exchange Policy 4.3, section 3.3.
• Statutory Hold Period – The Interest Shares will be subject to any applicable statutory hold period under Canadian securities laws.
• Contact for Further Information – Ian Atacan, Chief Financial Officer ([email protected]).

Notable Quotes

(No direct quotes were provided in the release.)